Connection
Thomas Jensen to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Thomas Jensen has written about Randomized Controlled Trials as Topic.
|
|
Connection Strength |
|
 |
|
 |
|
0.051 |
|
|
|
-
Crowley MJ, McGuire DK, Alexopoulos AS, Jensen TJ, Rasmussen S, Saevereid HA, Verma S, Buse JB. Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial. Diabetes Care. 2020 09; 43(9):e108-e110.
Score: 0.030
-
van den Brink W, Strang J, Gual A, S?rensen P, Jensen TJ, Mann K. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme. Expert Opin Drug Saf. 2015 Apr; 14(4):495-504.
Score: 0.021